Catheter Precision Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.9M+356.0% YoYTTM through 30 Jun 2026
Net Income -$13MTTM through 30 Jun 2026
Free Cash Flow -$9.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 90.3% |
| EBITDA Margin | -901.8% |
| Operating Margin | -1,000.3% |
| Net Margin | -679.1% |
Returns
-18.5%ROE
-35.3%ROA
Balance Sheet Health
Debt / Equity1.31x
Current Ratio0.06x
Net Debt$11.5M
Cash & Equivalents$643K
Quality Metrics
Altman Z-Score-13.94
Piotroski F-Score4 / 9
FCF Margin-489.5%
Earnings-Beat Rate0.0%
Multi-Year Trend
RevenueFY2025: $819K
Diluted EPSFY2025: $-15.90
Dividend
No dividend
Capital Allocation
Capex Intensity1.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medical Device Platform | +73.0% | View detailsContinued global commercialization and clinical adoption of VIVO and LockeT platforms. | |
| Aviation Platform | View detailsScaling the Flyte regional air mobility platform across additional high-frequency, short-haul markets. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.